Background Hemorrhagic transformation (HT) following reperfusion therapies for acute
ischaemic stroke often predicts a poor prognosis. This systematic review and meta-analysis …

Objective To determine the association of chronic kidney disease (CKD) with the safety and
efficacy of IV thrombolysis (IVT) among patients with acute ischemic stroke (AIS). Methods A …

Background The association between chronic kidney disease (CKD) and hemorrhagic
complications or clinical outcomes in patients treated with intravenous (IV) thrombolytic …

Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute
Ischemic Stroke in the Emergency Department - Annals of Emergency Medicine Skip to Main …

Renal Dysfunction and Thrombolytic Therapy in Patients With... : Medicine Renal Dysfunction
and Thrombolytic Therapy in Patients With Acute Ischemic Stroke: A Systematic Review and …

Background The relative frequency of ischaemic versus haemorrhagic stroke among
patients with chronic kidney disease (CKD) has not been clearly described. Moreover, no …

Background and purpose Renal dysfunction (ie a reduced estimated glomerular filtration
rate, eGFR) is commonly found in hospitalized stroke patients but its associations with …

Bone marrow mesenchymal stem cells (BMSCs) are used as a great promising choice for
the treatment of cerebral ischemia. Herein, we discuss the neuroprotective effects of the …

Background/Objectives: Chronic kidney disease (CKD) is identified as a risk factor for the
occurrence of ischemic stroke. There is substantial evidence that CKD is linked to a worse …

Objective. This study was set to assess the effect of renal dysfunction on outcome of stroke
patients treated with intravenous thrombolysis (IVT). Methods. This multicenter research …